Biokine Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Corporate

Biokine General Information

Description

Developer of novel drugs designed to identify novel molecular and cellular mechanisms that regulate tumor development and metastasis. The company's novel drugs offer cancer treatment, mainly leukemia and myeloma, thereby enabling healthcare industries to develop novel therapeutics against these devastating diseases.

Contact Information

Website
www.biokine.com
Formerly Known As
Biokine Therapeutics Ltd., Biokine Therapeutics, Biokine Therapeutics Limited
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Weizmann Science Park
  • PO Box: 2213
  • Rehovot 76120
  • Israel
+972
Primary Industry
Drug Discovery
Parent Company
BioLineRx
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Weizmann Science Park
  • PO Box: 2213
  • Rehovot 76120
  • Israel
+972

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biokine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Corporate 03-Oct-2018 Completed Generating Revenue
5. Merger/Acquisition Completed Generating Revenue
4. Grant 18-Mar-2009 Completed Generating Revenue
3. Later Stage VC 10-Jan-2007 Completed Generating Revenue
2. Grant $600K Completed Startup
1. Accelerator/Incubator 01-Jul-2000 Completed Startup
To view Biokine’s complete valuation and funding history, request access »

Biokine Patents

  • 196

    Total Documents Applications and Grants

  • Total Patents Families

  • 113

    Granted

  • 14

    Pending

  • Expiring in next 12 mo

Biokine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3205658-A1 Composition of bl-8040 Pending 30-Dec-2020
AU-2021412499-A1 Composition of bl-8040 Pending 30-Dec-2020
EP-4271402-A1 Composition of bl-8040 Pending 30-Dec-2020
US-20240131111-A1 Composition of bl-8040 Active 30-Dec-2020
US-20240092827-A1 Process for manufacturing peptide Active 30-Dec-2020 C07K1/20
To view Biokine’s complete patent history, request access »

Biokine Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Clal Biotechnology Industries Venture Capital Minority
European Union Government
Hadasit Bio-Holdings Corporation Minority
Israel Innovation Authority Government
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Biokine FAQs

  • When was Biokine founded?

    Biokine was founded in 2000.

  • Where is Biokine headquartered?

    Biokine is headquartered in Rehovot, Israel.

  • What industry is Biokine in?

    Biokine’s primary industry is Drug Discovery.

  • Is Biokine a private or public company?

    Biokine is a Private company.

  • What is Biokine’s current revenue?

    The current revenue for Biokine is .

  • How much funding has Biokine raised over time?

    Biokine has raised $594K.

  • Who are Biokine’s investors?

    , Clal Biotechnology Industries, European Union, Hadasit Bio-Holdings, and Israel Innovation Authority are 5 of 6 investors who have invested in Biokine.

  • When was Biokine acquired?

    Biokine was acquired on 03-Oct-2018.

  • Who acquired Biokine?

    Biokine was acquired by BioLineRx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »